Revenue (Tables)

9 Months Ended

Sep. 30, 2020

Revenue

Schedule of reportable segment included under sales category

	Three Months Ended September 30, 2020						Three Months Ended September 30, 2019
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	799	$	799	$	—	$	891	$	891
Other		—		300		300		—		321		321
Total		—		1,099		1,099		—		1,212		1,212
Nutritionals —
Pediatric Nutritionals		488		518		1,006		478		566		1,044
Adult Nutritionals		330		588		918		310		520		830
Total		818		1,106		1,924		788		1,086		1,874
Diagnostics —
Core Laboratory		284		892		1,176		272		905		1,177
Molecular		220		238		458		35		76		111
Point of Care		96		35		131		112		32		144
Rapid Diagnostics		533		342		875		283		194		477
Total		1,133		1,507		2,640		702		1,207		1,909
Medical Devices —
Rhythm Management		242		265		507		265		273		538
Electrophysiology		192		249		441		185		242		427
Heart Failure		144		46		190		136		50		186
Vascular		230		400		630		251		446		697
Structural Heart		159		194		353		158		190		348
Neuromodulation		170		36		206		165		39		204
Diabetes Care		226		617		843		175		490		665
Total		1,363		1,807		3,170		1,335		1,730		3,065
Other		15		5		20		9		7		16
Total	$	3,329	$	5,524	$	8,853	$	2,834	$	5,242	$	8,076

	Nine Months Ended September 30, 2020						Nine Months Ended September 30, 2019
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	2,376	$	2,376	$	—	$	2,496	$	2,496
Other		—		780		780		—		816		816
Total		—		3,156		3,156		—		3,312		3,312
Nutritionals —
Pediatric Nutritionals		1,490		1,629		3,119		1,406		1,718		3,124
Adult Nutritionals		948		1,644		2,592		915		1,502		2,417
Total		2,438		3,273		5,711		2,321		3,220		5,541
Diagnostics —
Core Laboratory		840		2,312		3,152		793		2,614		3,407
Molecular		429		527		956		113		213		326
Point of Care		278		109		387		334		90		424
Rapid Diagnostics		1,246		719		1,965		881		617		1,498
Total		2,793		3,667		6,460		2,121		3,534		5,655
Medical Devices —
Rhythm Management		655		727		1,382		790		810		1,600
Electrophysiology		476		652		1,128		549		713		1,262
Heart Failure		411		140		551		428		143		571
Vascular		628		1,108		1,736		787		1,349		2,136
Structural Heart		386		508		894		446		578		1,024
Neuromodulation		392		97		489		485		124		609
Diabetes Care		614		1,736		2,350		485		1,348		1,833
Total		3,562		4,968		8,530		3,970		5,065		9,035
Other		30		20		50		26		21		47
Total	$	8,823	$	15,084	$	23,907	$	8,438	$	15,152	$	23,590

Schedule of changes in contract liabilities

(in millions)
Contract Liabilities
Balance at December 31, 2019	$	294
Unearned revenue from cash received during the period		350
Revenue recognized related to contract liability balance		(293)
Balance at September 30, 2020	$	351